PROFILE COMMISSION |
|
Shilov E.M., Shilova M.M., Rumyantseva E.I., Batyushin M.M., Bevzenko A.Yu., Belskikh A.N., Veselkova N.V., Yesayan A.M., Ivliev S.V., Kotenko O.N., Petrova N.Yu., Statsenko M.E., Stolyar A.G.
Nephrological service of the Russian Federation 2022: post-covid period
|
5-17 |
ORIGINAL PAPERS |
|
Sokolova A.V., Dragunov D.O., Arutyunov G.P.
The prevalence of sarcopenia in patients with chronic heart failure and chronic kidney disease
|
18-23 |
Yakovenko A.A., Lavrishcheva Yu.V., Rumyantsev A.Sh., Belskikh A.N.
The significance of TNF-α in the pathogenesis of protein-energy malnutrition in patients on program hemodialysis
|
24-29 |
Moiseev S.V., Shchulkin A.V., Abalenikhina Yu.V., Mylnikov P.Yu., Yakusheva E.N., Khmelevsky M.S., Matsiyak M.V.
Double-blind, randomized, phase I trial comparing the pharmacokinetics and safety of agalsidase beta bioanaloguer (Fabagal®) and the original drug (Fabrazim®) in healthy volunteers
|
30-36 |
Pyatchenkov M.O., Sherbakov E.V., Trandidna A.E., Belskykh A.N.
Intestinal fatty acid binding protein as biomarker of enterocyte injury in patients with renal failure
|
37-41 |
NEPHROUROLOGY |
|
Vtorenko V.I., Trushkin R.N., Medvedev P.E., Vinogradov V.E., Isaev T.K., Sokolov S.A., Bondarenko S.A., Kolesnikov N.O., Ivanov K.V.
The use of bilateral total transarterial renal embolization for the combined treatment of patients with symptomatic autosomal dominant polycystic kidney disease and end-stage renal disease
|
42-51 |
Nasirov A.A., Khotamov Kh.N., Baiakhmedov F.F., Khoshimov T.R.
The choice of surgical tactics for calculous anuria in infants
|
52-55 |
LITERATURE REVIEWS |
|
Subotyalov M.A.
Development of ideas about urolithiasis
|
56-60 |
Murkamilov I.T., Fomin V.V., Sabirov I.S., Yusupov F.A., Satkynalieva Z.T.
Acute tubulointerstitial nephritis of medicinal etiology: the focus is on antibacterial drugs
|
61-68 |
The Opinion of the Experts |
|
Shilov E.M.
Formulas for estimating glomerular filtration rate: correct and incorrect use
|
69-71 |
CONSENSUS |
|
Avdeev S.N., Chulanov V.P., Alexeeva E.I., Aleshina O.A., Bereznikov A.V., Kotenko O.N., Lila A.M., Mutovina Z.Yu, Parovichnikova E.N., Fomina D.S., Frolova N.F., Shevchenko A.O.
The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic
|
72-79 |